Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![PTC Therapeutics, Inc. Graphic](https://lunarcrush.com/gi/w:26/t:$ptct.png) PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics (PTCT) stock holds near a 1-year high despite FDA rejection of Vatiquinone. Positive analyst ratings and AI stock rankings are buoying the stock.

### About PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company.  
PTC Therapeutics, Inc. uses the ticker $PTCT for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$ptct/insights)
- PTC Therapeutics, Inc. (PTCT) trading volume is up XXXXX% from the previous week.
- PTC Therapeutics, Inc. (PTCT) social dominance is up XXXXXX% from the previous month.
- PTC Therapeutics, Inc. Price hit a 52-Week high of XX for the hour
- PTC Therapeutics, Inc. Price hit an all time of XX for the hour

### Price: $XX [#](/topic/$ptct/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/close.tsv)  
The price is holding steady near its 1-year high despite the FDA rejection, likely due to positive analyst ratings, inclusion in AI stock rankings, and the market potentially pricing in future potential.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXX%  |

**1-Year High**: $XXXXX on 2025-10-15  
**1-Year Low**: $XXXXX on 2025-05-06  
  
  
### AltRank: XXX [#](/topic/$ptct/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/alt_rank.tsv)  
PTC Therapeutics, Inc. (PTCT) is currently AltRank #703 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +1,015  
**1 Month**: XXX +502  
**6 Months**: XXX +494  
**1 Year**: XXX +211  
**1-Year High**: XXXXX on 2025-07-26  
**1-Year Low**: XX on 2024-12-02  
  
  
### Galaxy Score: XXXXX [#](/topic/$ptct/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX +1  
**6 Months**: XX -XX  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-06-23  
**1-Year Low**: XX on 2025-08-28  
  
  
### Engagements: XXX [#](/topic/$ptct/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXXXX +22%  
**1 Year**: XXXXXXXXX +80%  
**1-Year High**: XXXXXX on 2024-12-02  
**1-Year Low**: XXX on 2025-09-18  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$ptct/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +16%  
**1 Year**: XXXXX +203%  
**1-Year High**: XXX on 2024-12-05  
**1-Year Low**: X on 2025-10-12  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$ptct/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning PTC Therapeutics, Inc. (PTCT) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXXXX +75%  
**1 Year**: XXXXX +258%  
**1-Year High**: XXX on 2025-06-30  
**1-Year Low**: X on 2025-10-12  

The most influential creators that mention PTC Therapeutics, Inc. in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@byul_finance](/creator/twitter/byul_finance) | X    | XXX       | X     | X           |

[View More](/list/creators/$ptct/100)
  
  
### Sentiment: XXX% [#](/topic/$ptct/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +33%  
**6 Months**: XXX% +17%  
**1 Year**: XXX% +50%  
**1-Year High**: XXX% on 2024-11-01  
**1-Year Low**: XX% on 2025-04-12  

**Most Supportive Themes**
- **Positive Analyst Ratings and Price Targets:** (35%) Posts highlight positive analyst ratings and price targets for PTCT, suggesting potential upside.
- **Mentions in AI and Momentum Stock Screeners:** (30%) PTCT is featured in AI-driven stock rankings and momentum screeners, indicating positive technical and fundamental scores.
- **Inclusion in Biotech Stock Lists:** (15%) PTCT is included in lists of strong biotech stocks, suggesting positive sentiment within the biotech sector.
  
**Most Critical Themes**
- **FDA Complete Response Letter for Vatiquinone:** (40%)  The FDA's rejection of the NDA for vatiquinone due to insufficient efficacy is a major negative catalyst.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XXX     | XX% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$ptct/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXXX% +0.00043999999999999985%  
**1 Month**: XXXXX% +0.0027%  
**6 Months**: XXXXX% -XXXXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-12-05  
**1-Year Low**: XXXXXX% on 2025-10-12  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$ptct/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-04-09  
**1-Year Low**: XXXXXXX% on 2025-05-06  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$ptct/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX -$1.10%  
**1 Month**: $XXXXXXXXXXXXX +$4.90%  
**6 Months**: $XXXXXXXXXXXXX +$40%  
**1 Year**: $XXXXXXXXXXXXX +$75%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-10-15  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-05-06  

**Top assets mentioned**
In the posts about PTC Therapeutics, Inc. in the last XX hours

[Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan)
[uniQure N.V. (QURE)](/topic/$qure)
[Perrigo Company PLC (PRGO)](/topic/$prgo)
[Corcept Therapeutics Inc. (CORT)](/topic/$cort)
[Biogen Inc (BIIB)](/topic/biogen-inc)
[Akropolis (AKRO)](/topic/$akro)
[Vaxcyte, Inc. Common Stock (PCVX)](/topic/$pcvx)
[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm)

**Top topics mentioned**
In the posts about PTC Therapeutics, Inc. in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [coins defi](/topic/coins-defi), [stocks technology](/topic/stocks-technology), [investment](/topic/investment), [$elan](/topic/$elan), [coins base ecosystem](/topic/coins-base-ecosystem), [$qure](/topic/$qure), [$prgo](/topic/$prgo), [stocks](/topic/stocks), [$cort](/topic/$cort), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [biogen inc](/topic/biogen-inc), [$akro](/topic/$akro), [$pcvx](/topic/$pcvx), [$mrus](/topic/$mrus), [$rytm](/topic/$rytm), [$crsp](/topic/$crsp), [$bmrn](/topic/$bmrn), [stocks financial services](/topic/stocks-financial-services), [coins dao](/topic/coins-dao), [$agi](/topic/$agi), [$abvx](/topic/$abvx), [$bbio](/topic/$bbio), [telegram](/topic/telegram), [$biib](/topic/$biib), [$ions](/topic/$ions), [$vctr](/topic/$vctr), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [tesla](/topic/tesla), [$wves](/topic/$wves), [$nvo](/topic/$nvo), [gsk plc](/topic/gsk-plc), [$gsk](/topic/$gsk), [coins made in usa](/topic/coins-made-in-usa), [coins solana ecosystem](/topic/coins-solana-ecosystem), [coins arbitrum](/topic/coins-arbitrum), [$prva](/topic/$prva), [vivo](/topic/vivo), [$rrhby](/topic/$rrhby), [$nvs](/topic/$nvs), [stocks industrials](/topic/stocks-industrials), [$lpl](/topic/$lpl), [$lrcx](/topic/$lrcx), [$bros](/topic/$bros), [$nams](/topic/$nams), [$skyw](/topic/$skyw), [$lnc](/topic/$lnc), [$roiv](/topic/$roiv), [$rvmd](/topic/$rvmd), [$rgc](/topic/$rgc), [$tvtx](/topic/$tvtx), [$mirm](/topic/$mirm), [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc), [$nbix](/topic/$nbix), [$kymr](/topic/$kymr), [dyne therapeutics](/topic/dyne-therapeutics), [$dyn](/topic/$dyn), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$gva](/topic/$gva), [autodesk inc](/topic/autodesk-inc), [$bipc](/topic/$bipc), [united states](/topic/united-states), [$bntx](/topic/$bntx), [$llc](/topic/$llc), [$arwr](/topic/$arwr), [$alks](/topic/$alks), [$acad](/topic/$acad), [$skye](/topic/$skye), [$ntla](/topic/$ntla), [$chgg](/topic/$chgg), [$116k](/topic/$116k), [$cxw](/topic/$cxw), [$388k](/topic/$388k), [$flg](/topic/$flg), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$regn](/topic/$regn), [$rhhby](/topic/$rhhby), [coins meme](/topic/coins-meme), [$acls](/topic/$acls), [$vsec](/topic/$vsec), [$apa](/topic/$apa), [$adma](/topic/$adma), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [filings](/topic/filings), [$reta](/topic/$reta), [coins zk](/topic/coins-zk), [$noah](/topic/$noah), [$negg](/topic/$negg), [$crdo](/topic/$crdo), [$mtrx](/topic/$mtrx), [ticker](/topic/ticker), [$opch](/topic/$opch), [$mu](/topic/$mu), [$vrt](/topic/$vrt), [$adpt](/topic/$adpt), [$abbv](/topic/$abbv), [$kala](/topic/$kala), [rating agency](/topic/rating-agency), [$xbi](/topic/$xbi)

### Top Social Posts [#](/topic/$ptct/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Strong growth but not overvalued . $PTCT $AGI $VCTR $SMCI $SUPN $VRTX $MNSO and $CTRA are showing up in our selection"  
[X Link](https://x.com/ChartMill/status/1978581651463540908) [@ChartMill](/creator/x/ChartMill) 2025-10-15T22:00Z 11.2K followers, XXX engagements


"Huntingtons Disease Clinical Research Congress 2025 Day X Discussion about clinical trials in progress from $QURE $PTCT & Roche"  
[X Link](https://x.com/DesertDweller93/status/1978557465575805153) [@DesertDweller93](/creator/x/DesertDweller93) 2025-10-15T20:23Z 3865 followers, 5097 engagements


"Seven commercial in vivo gene therapies for rare diseases: Luxturna (RPE65-LCA2; $RRHBY) Zolgensma (SMA; $NVS) Kebilidi (AADC deficiency; $PTCT) Roctavian (HemA; $BMRN) Hemgenix (HemB; $QURE) and Elevidys (DMD; $SRPT) using AAV vectors and Vykuvek (DEB; $KRYS) using Herpesvirus. Zolgensma is a blockbuster ($1bn+ net sales/year). Elevidys was on-track to become one (strong demand) despite all the issues associated with systemic gene therapy. Luxturna has had strong demand but so few patients that the commercial case has been very challenging. Vyjuvek did $300M in revenues the first full-year"  
[X Link](https://x.com/GerardCaelles/status/1978550460983197811) [@GerardCaelles](/creator/x/GerardCaelles) 2025-10-15T19:56Z 1099 followers, XXX engagements


"Monster in the making $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"  
[X Link](https://x.com/mariostario2019/status/1978135556371444180) [@mariostario2019](/creator/x/mariostario2019) 2025-10-14T16:27Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

PTC Therapeutics, Inc. Graphic PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics (PTCT) stock holds near a 1-year high despite FDA rejection of Vatiquinone. Positive analyst ratings and AI stock rankings are buoying the stock.

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company.
PTC Therapeutics, Inc. uses the ticker $PTCT for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • PTC Therapeutics, Inc. (PTCT) trading volume is up XXXXX% from the previous week.
  • PTC Therapeutics, Inc. (PTCT) social dominance is up XXXXXX% from the previous month.
  • PTC Therapeutics, Inc. Price hit a 52-Week high of XX for the hour
  • PTC Therapeutics, Inc. Price hit an all time of XX for the hour

Price: $XX #

Price Line Chart
Price 24-Hour Time-Series Raw Data
The price is holding steady near its 1-year high despite the FDA rejection, likely due to positive analyst ratings, inclusion in AI stock rankings, and the market potentially pricing in future potential.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% XXXX%

1-Year High: $XXXXX on 2025-10-15
1-Year Low: $XXXXX on 2025-05-06

AltRank: XXX #

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
PTC Therapeutics, Inc. (PTCT) is currently AltRank #703 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +1,015
1 Month: XXX +502
6 Months: XXX +494
1 Year: XXX +211
1-Year High: XXXXX on 2025-07-26
1-Year Low: XX on 2024-12-02

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX +1
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-06-23
1-Year Low: XX on 2025-08-28

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX +22%
1 Year: XXXXXXXXX +80%
1-Year High: XXXXXX on 2024-12-02
1-Year Low: XXX on 2025-09-18

Social Network X
Engagements XXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +16%
1 Year: XXXXX +203%
1-Year High: XXX on 2024-12-05
1-Year Low: X on 2025-10-12

Social Network X
Mentions XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning PTC Therapeutics, Inc. (PTCT) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +75%
1 Year: XXXXX +258%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-10-12

The most influential creators that mention PTC Therapeutics, Inc. in the last XX hours

Creator Rank Followers Posts Engagements
@byul_finance X XXX X X

View More

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +33%
6 Months: XXX% +17%
1 Year: XXX% +50%
1-Year High: XXX% on 2024-11-01
1-Year Low: XX% on 2025-04-12

Most Supportive Themes

  • Positive Analyst Ratings and Price Targets: (35%) Posts highlight positive analyst ratings and price targets for PTCT, suggesting potential upside.
  • Mentions in AI and Momentum Stock Screeners: (30%) PTCT is featured in AI-driven stock rankings and momentum screeners, indicating positive technical and fundamental scores.
  • Inclusion in Biotech Stock Lists: (15%) PTCT is included in lists of strong biotech stocks, suggesting positive sentiment within the biotech sector.

Most Critical Themes

  • FDA Complete Response Letter for Vatiquinone: (40%) The FDA's rejection of the NDA for vatiquinone due to insufficient efficacy is a major negative catalyst.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX XX% XXX XX% X X%
Total XX XX% XXX XX% X X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00043999999999999985%
1 Month: XXXXX% +0.0027%
6 Months: XXXXX% -XXXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-05
1-Year Low: XXXXXX% on 2025-10-12

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-09
1-Year Low: XXXXXXX% on 2025-05-06

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$1.10%
1 Month: $XXXXXXXXXXXXX +$4.90%
6 Months: $XXXXXXXXXXXXX +$40%
1 Year: $XXXXXXXXXXXXX +$75%
1-Year High: $XXXXXXXXXXXXX on 2025-10-15
1-Year Low: $XXXXXXXXXXXXX on 2025-05-06

Top assets mentioned In the posts about PTC Therapeutics, Inc. in the last XX hours

Elanco Animal Health Incorporated Common Stock (ELAN) uniQure N.V. (QURE) Perrigo Company PLC (PRGO) Corcept Therapeutics Inc. (CORT) Biogen Inc (BIIB) Akropolis (AKRO) Vaxcyte, Inc. Common Stock (PCVX) Merus N.V. Common Shares (MRUS) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)

Top topics mentioned In the posts about PTC Therapeutics, Inc. in the last XX hours

stocks healthcare, coins defi, stocks technology, investment, $elan, coins base ecosystem, $qure, $prgo, stocks, $cort, stocks bitcoin treasuries, biogen inc, $akro, $pcvx, $mrus, $rytm, $crsp, $bmrn, stocks financial services, coins dao, $agi, $abvx, $bbio, telegram, $biib, $ions, $vctr, stocks consumer cyclical, tesla, $wves, $nvo, gsk plc, $gsk, coins made in usa, coins solana ecosystem, coins arbitrum, $prva, vivo, $rrhby, $nvs, stocks industrials, $lpl, $lrcx, $bros, $nams, $skyw, $lnc, $roiv, $rvmd, $rgc, $tvtx, $mirm, neurocrine biosciences inc, $nbix, $kymr, dyne therapeutics, $dyn, sarepta therapeutics inc, $gva, autodesk inc, $bipc, united states, $bntx, $llc, $arwr, $alks, $acad, $skye, $ntla, $chgg, $116k, $cxw, $388k, $flg, regeneron pharmaceuticals inc, $regn, $rhhby, coins meme, $acls, $vsec, $apa, $adma, stocks bitcoin miners, stocks crypto treasuries, filings, $reta, coins zk, $noah, $negg, $crdo, $mtrx, ticker, $opch, $mu, $vrt, $adpt, $abbv, $kala, rating agency, $xbi

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Strong growth but not overvalued . $PTCT $AGI $VCTR $SMCI $SUPN $VRTX $MNSO and $CTRA are showing up in our selection"
X Link @ChartMill 2025-10-15T22:00Z 11.2K followers, XXX engagements

"Huntingtons Disease Clinical Research Congress 2025 Day X Discussion about clinical trials in progress from $QURE $PTCT & Roche"
X Link @DesertDweller93 2025-10-15T20:23Z 3865 followers, 5097 engagements

"Seven commercial in vivo gene therapies for rare diseases: Luxturna (RPE65-LCA2; $RRHBY) Zolgensma (SMA; $NVS) Kebilidi (AADC deficiency; $PTCT) Roctavian (HemA; $BMRN) Hemgenix (HemB; $QURE) and Elevidys (DMD; $SRPT) using AAV vectors and Vykuvek (DEB; $KRYS) using Herpesvirus. Zolgensma is a blockbuster ($1bn+ net sales/year). Elevidys was on-track to become one (strong demand) despite all the issues associated with systemic gene therapy. Luxturna has had strong demand but so few patients that the commercial case has been very challenging. Vyjuvek did $300M in revenues the first full-year"
X Link @GerardCaelles 2025-10-15T19:56Z 1099 followers, XXX engagements

"Monster in the making $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"
X Link @mariostario2019 2025-10-14T16:27Z XX followers, XXX engagements

PTC Therapeutics, Inc. (PTCT)
/topic/$ptct